BACKGROUND: Elimination of wasteful diagnostic testing will improve value for the United States health care system. OBJECTIVE: Design and implement a multimodal intervention to improve evidence-based ordering of cardiac biomarkers for the diagnosis of acute coronary syndrome (ACS). DESIGN: Interrupted times series. SUBJECTS: A total of 60,494 adult inpatient admissions from January 2009 through July 2011 (pre-intervention) and 24,341 admissions from November 2011 through October 2012 (post-intervention) at an academic medical center in Baltimore, Maryland. INTERVENTION: Multimodal intervention introduced August through October 2011 that included dissemination of an institutional guideline and changes to the computerized provider order entry system. MAIN MEASURES: The primary outcome was percentage of patients with guideline-concordant ordering of cardiac biomarkers, defined as three or fewer troponin tests and zero CK-MB tests in patients without a diagnosis of ACS. Secondary outcomes included counts of tests ordered per patient, incidence of diagnosis of ACS, and estimated change in charges for cardiac biomarker tests in the post-intervention period. KEY RESULTS: Twelve months following the intervention, we estimated that guideline-concordant ordering of cardiac biomarkers increased from 57.1 % to 95.5 %, an absolute increase of 38.4 % (95 % CI, 36.4 % to 40.4 %). We estimated that the intervention led to a 66 % reduction in the number of tests ordered, and a $1.25 million decrease in charges over the first year. At 12 months, there was an estimated absolute increase in incidence of primary diagnosis of ACS of 0.3 % (95 % CI, 0.0 % to 0.5 %) compared with the expected baseline rate. CONCLUSIONS: We implemented a multimodal intervention that significantly increased guideline-concordant ordering of cardiac biomarker testing, leading to substantial reductions in tests ordered without impacting diagnostic yield. A trial of this approach at other institutions and for other diagnostic tests is warranted and if successful, would represent a framework for eliminating wasteful diagnostic testing.
BACKGROUND: Elimination of wasteful diagnostic testing will improve value for the United States health care system. OBJECTIVE: Design and implement a multimodal intervention to improve evidence-based ordering of cardiac biomarkers for the diagnosis of acute coronary syndrome (ACS). DESIGN: Interrupted times series. SUBJECTS: A total of 60,494 adult inpatient admissions from January 2009 through July 2011 (pre-intervention) and 24,341 admissions from November 2011 through October 2012 (post-intervention) at an academic medical center in Baltimore, Maryland. INTERVENTION: Multimodal intervention introduced August through October 2011 that included dissemination of an institutional guideline and changes to the computerized provider order entry system. MAIN MEASURES: The primary outcome was percentage of patients with guideline-concordant ordering of cardiac biomarkers, defined as three or fewer troponin tests and zero CK-MB tests in patients without a diagnosis of ACS. Secondary outcomes included counts of tests ordered per patient, incidence of diagnosis of ACS, and estimated change in charges for cardiac biomarker tests in the post-intervention period. KEY RESULTS: Twelve months following the intervention, we estimated that guideline-concordant ordering of cardiac biomarkers increased from 57.1 % to 95.5 %, an absolute increase of 38.4 % (95 % CI, 36.4 % to 40.4 %). We estimated that the intervention led to a 66 % reduction in the number of tests ordered, and a $1.25 million decrease in charges over the first year. At 12 months, there was an estimated absolute increase in incidence of primary diagnosis of ACS of 0.3 % (95 % CI, 0.0 % to 0.5 %) compared with the expected baseline rate. CONCLUSIONS: We implemented a multimodal intervention that significantly increased guideline-concordant ordering of cardiac biomarker testing, leading to substantial reductions in tests ordered without impacting diagnostic yield. A trial of this approach at other institutions and for other diagnostic tests is warranted and if successful, would represent a framework for eliminating wasteful diagnostic testing.
Authors: Ronit Calderon-Margalit; Shlomo Mor-Yosef; Michael Mayer; Bella Adler; Shmuel C Shapira Journal: Int J Qual Health Care Date: 2005-04-18 Impact factor: 2.038
Authors: David A Morrow; Christopher P Cannon; Robert L Jesse; L Kristin Newby; Jan Ravkilde; Alan B Storrow; Alan H B Wu; Robert H Christenson Journal: Circulation Date: 2007-03-23 Impact factor: 29.690
Authors: Kanya Kumwilaisak; Alberto Noto; Ulrich H Schmidt; Clare I Beck; Claudia Crimi; Kent Lewandrowski; Luca M Bigatello Journal: Crit Care Med Date: 2008-11 Impact factor: 7.598
Authors: Ashly D Black; Josip Car; Claudia Pagliari; Chantelle Anandan; Kathrin Cresswell; Tomislav Bokun; Brian McKinstry; Rob Procter; Azeem Majeed; Aziz Sheikh Journal: PLoS Med Date: 2011-01-18 Impact factor: 11.069
Authors: Jennifer K Maratt; Eve A Kerr; Mandi L Klamerus; Shannon E Lohman; Whit Froehlich; R Sacha Bhatia; Sameer D Saini Journal: J Gen Intern Med Date: 2019-06-27 Impact factor: 5.128
Authors: Brian J Hachey; Michael C Kontos; L Kristin Newby; Robert H Christenson; W Frank Peacock; Katherine C Brewer; James McCord Journal: J Am Heart Assoc Date: 2017-09-22 Impact factor: 5.501
Authors: Jeremiah S Hinson; Binoy Mistry; Yu-Hsiang Hsieh; Nicholas Risko; David Scordino; Karolina Paziana; Susan Peterson; Rodney Omron Journal: West J Emerg Med Date: 2017-01-30
Authors: Renuka S Bindraban; Maarten J Ten Berg; Christiana A Naaktgeboren; Mark H H Kramer; Wouter W Van Solinge; Prabath W B Nanayakkara Journal: Ann Lab Med Date: 2018-09 Impact factor: 3.464
Authors: Alan M Ducatman; Danyel H Tacker; Barbara S Ducatman; Dustin Long; Peter L Perrotta; Hannah Lawther; Kelly Pennington; Owen Lander; Mary Warden; Conard Failinger; Kevin Halbritter; Ronald Pellegrino; Marney Treese; Jeffrey A Stead; Eric Glass; Lauren Cianciaruso; Konrad C Nau Journal: Acad Pathol Date: 2017-05-28